✦ LIBER ✦

In vivo and in vitro evaluation of a microencapsulated narcotic antagonist

✍ Scribed by Norbert Mason; Curt Thies; Theodore J. Cicero

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 716 KB
Volume: 65
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600650612

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo release of microenc

In vitro and in vivo release of microencapsulated chlorothiazide

✍ J. R. Nixon 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 1 views

Retention and outcome in a narcotic anta

Retention and outcome in a narcotic antagonist treatment program

✍ Dr. Thomas Capone; Leonard Brahen; Raymond Condren; Nancy Kordal; Ronald Melchio 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

In vitro and in vivo evaluation of two u

In vitro and in vivo evaluation of two ultrashort-acting beta-adrenoreceptor antagonists: ACC-9129 and ACC-9369

✍ J. E. Shaffer; A. Vuong; R. J. Gorczynski; W. L. Matier 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

ACC-9129 and ACC-9369 were evaluated in guinea pig isolated atria and trachea and in anesthetized dogs and conscious rabbits for beta-blocking potency, duration of action, and intraocular pressure effects. ACC-9129 showed competitive cardioselective beta-blocking activity, with a pA2 of 6.8 in guine

In vitro and In vivo Evaluation of Docet

In vitro and In vivo Evaluation of Docetaxel Loaded Biodegradable Polymersomes

✍ Kamal K. Upadhyay; Anant N. Bhatt; Emilio Castro; Anil K. Mishra; Krishna Chutta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

## Abstract Formulation of docetaxel (DOC), a hydrophobic anticancer drug, was successfully achieved in poly(γ‐benzyl L‐glutamate)‐__block__‐hyaluronan polymersomes using a simple and reproducible nanoprecipitation method. The prepared DOC loaded polymersomes (PolyDOC) was stable either in solution

Comparison of in vivo and in vitro mouse

Comparison of in vivo and in vitro mouse bioassays for botulinum toxin antagonists

✍ Robert E. Sheridan; Sharad S. Deshpande; Theresa Smith 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Measurements of the efficacy of novel botulinum toxin antagonists can be based on classical bioassays of toxin concentration. However, the relative sensitivities of in vivo and in vitro assays to the effects of antagonists are not necessarily correlated with the sensitivities of the assays to toxin.

In vitro and in vivo evaluation of Adaco

In vitro and in vivo evaluation of Adacolumn ® cytapheresis in healthy subjects

✍ Wolfgang Ramlow; Jorg Emmrich; Peter Ahrenholz; Gisela Sparmann; Nobuhito Kashiw 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Adacolumn^®^ is a medical device for adsorptive cytapheresis. It has been developed for selective adsorption of granulocytes and monocytes from peripheral blood of patients with immune disorders, such as autoimmune diseases and chronic inflammatory diseases. A double blind sham‐controll